Tag Archives: fda

Children’s and infant’s Tylenol, Motrin, Zyrtec and Benadryl recalled

The FDA is telling parents to avoid giving their children the child and infant versions of Tylenol, Motrin, Benadryl, and Zyrtec products, due to safety problems. Following FDA discussions, manufacturer McNeil Consumer Healthcare has pulled the products from the market. … Continue reading

Posted in Defective Drugs | Tagged , , , , , |

Secret tapes of Avandia-maker meeting reveal deceptions

Secret tapes of a meeting between GlaxoSmithKline (GSK) executives and a prominent medical researcher reveal deceptive tactics by the company, according to a Feb. 22 New York Times article detailing the recordings, which were never previously disclosed. In 2007, GSK … Continue reading

Posted in Avandia, Scientific Journal Articles, heart attacks | Tagged , , , , |

FDA doctors say Avandia “should be removed from the market”

Two FDA epidemiologists have said the diabetes drug Avandia (rosiglitazone) should be pulled from the market due to increased risk of heart failure and heart attacks. David Graham, MD, and Kate Gelperin, MD, both epidemiologists with the FDA, where quoted … Continue reading

Posted in Avandia, heart attacks | Tagged , , |

FDA lists drugs under review for possible safety issues

The FDA has released a list of drugs the agency is reviewing drugs for possible safety issues. Some of the drugs have been noted for safety issues previously, resulting in forced label changes. The list includes: the cancer drug Sutent; … Continue reading

Posted in Defective Drugs | Tagged , , |

Xolair possibly linked to heart attack and stroke

The FDA warned on July 16 that asthma drug Xolair may be linked to increased risk of heart attacks and strokes. Xolair is sold in the U.S. by Novartis and Genentech, a division of Roche. An ongoing study has revealed … Continue reading

Posted in Defective Drugs, heart attacks, stroke | Tagged , , , , , , |